Finzati - Logo
NHNKF logo

Nihon Kohden Corporation

NHNKFMedical - Devices
$9.60
0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.56B
Growth
2.1%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive free cash flow · 94.86Consistent free cash flow · 4/5Manageable debt level · 0.14Healthy liquidity · 3.6Negative growth trend
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$9.60
Change0.00%
Shares Out162.28M
Market Cap$1.56B
52W Range10.90 - 15.07
Beta0.23
P/E16.96
P/S1.05
P/B1.37
P/FCF16.06
EV/Sales1.60
EV/EBITDA15.28

Investment DNA

How strong this company looks for long-term investors

58
out of 100
Business Quality
Margins, moat, returns
39/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score
Positive free cash flow · 94.86Consistent free cash flow · 4/5Manageable debt level · 0.14Healthy liquidity · 3.6Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 2/18/2020
Industry: Medical - Devices
P/B i: 1.37
Debt / Equity i: 0.14
Operating Margin: 7.99%
Net Margin: 6.17%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.14
Current Ratio: 3.60
Quick Ratio: 2.46
Status: Strong
🧾

No insider activity

No recent insider transactions available.